Supervivencia en pacientes con EPOC en tratamiento con oxigenoterapia continua domiciliaria

Supervivencia en pacientes con EPOC en tratamiento con oxigenoterapia continua domiciliaria

Resumen: Introducción: La oxigenoterapia continua domiciliara (OCD) es el primer tratamiento que ha demostrado aumentar la supervivencia de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) e hipoxemia crónica, junto con el abandono del consumo de tabaco. Objetivo: Conocer la supervi...

Full description

Bibliographic Details
Main Authors:	María del Carmen García García, Jacinto Hernández Borge, Gema María García García, Francisca Lourdes Márquez Pérez
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Open Respiratory Archives
Subjects:	COPD Continuous home oxygen therapy Survival Respiratory failure Comorbidities Exacerbations
Online Access:	http://www.sciencedirect.com/science/article/pii/S2659663621000382

Similar Items

Calidad de vida en pacientes EPOC con oxigenoterapia crónica domiciliaria
by: Noélia A. Balbo, et al.
Published: (2018-09-01)

Oxigenoterapia continua domiciliaria
by: José Miguel Rodríguez González-Moro, et al.
Published: (2020-04-01)

Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
by: Youngmee Kim, et al.
Published: (2021-05-01)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)

A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
by: Wilhelm Bertrams, et al.
Published: (2024-03-01)

Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study
by: Juan Marco Figueira‐Gonçalves, et al.
Published: (2022-07-01)

Adecuada prescripción clínica de la oxigenoterapia continua domiciliaria
by: Sarah María Regueira Betancourt, et al.
Published: (2015-12-01)

Impact of mild exacerbation on COPD symptoms in a Japanese cohort
by: Sato M, et al.
Published: (2016-06-01)

Clinical heterogeneity of a population of patients admitted to the Emergency Department with a diagnosis of COPD-exacerbation: Relevance of cardiovascular comorbidities
by: Paolo Groff, et al.
Published: (2021-03-01)

Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions
by: Amado CA, et al.
Published: (2020-10-01)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
by: Kathrin Kahnert, et al.
Published: (2018-06-01)

Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD
by: Mekov E, et al.
Published: (2022-05-01)

Tratamiento con oxigenoterapia de alto flujo en las crisis asmáticas en la planta de hospitalización de pediatría: nuestra experiencia
by: Felipe González Martínez, et al.
Published: (2019-02-01)

Utilidad del miniespirómetro COPD-6 en el diagnóstico precoz de EPOC
by: María de los Ángeles Rosero Arenas, et al.
Published: (2020-07-01)

Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece
by: Despo Ierodiakonou, et al.
Published: (2020-09-01)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
by: Whittaker H, et al.
Published: (2022-03-01)

One-year mortality after severe COPD exacerbation in Bulgaria
by: Evgeni Mekov, et al.
Published: (2016-12-01)

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal
by: Achim Grünewaldt, et al.
Published: (2022-12-01)

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
by: John R. Hurst, et al.
Published: (2022-08-01)

Clinical factors and comorbidities affecting the cost of hospital-treated COPD
by: Deniz S, et al.
Published: (2016-12-01)

Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis
by: Yoon HY, et al.
Published: (2019-06-01)

Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations
by: Mahboub B, et al.
Published: (2016-02-01)

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
by: Kalhan R, et al.
Published: (2021-04-01)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
by: Calverley PMA, et al.
Published: (2017-11-01)

The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
by: Wise RA, et al.
Published: (2021-03-01)

Soporte telefónico al paciente con EPOC en tiempos de la COVID-19
by: José Luis Lopez-Campos, et al.
Published: (2020-07-01)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
by: Miłkowska-Dymanowska J, et al.
Published: (2018-11-01)

Conocimiento de la enfermedad pulmonar obstructiva crónica (EPOC) en la población gallega: estudio «CoñecEPOC»
by: Cristina Represas-Represas, et al.
Published: (2021-07-01)

A year in the life of German patients with COPD: the DACCORD observational study
by: Buhl R, et al.
Published: (2016-07-01)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP
by: Ge H, et al.
Published: (2021-07-01)

Infección bronquial crónica en EPOC estable
by: Juan José Soler-Cataluña, et al.
Published: (2023-01-01)

¿Mienten los pacientes con EPOC sobre su hábito tabáquico?
by: Virginia Almadana Pacheco, et al.
Published: (2020-10-01)

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study
by: Ferguson GT, et al.
Published: (2020-11-01)

Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease
by: Fanny Wai-san Ko, et al.
Published: (2019-09-01)

Thrombelastography and Conventional Coagulation Markers in Chronic Obstructive Pulmonary Disease: A Prospective Paired-Measurements Study Comparing Exacerbation and Stable Phases
by: Ema Rastoder, et al.
Published: (2024-02-01)

Factors associated with hospital admission in patients reaching the emergency department with COPD exacerbation
by: García-Sanz Maria, et al.
Published: (2012-06-01)

Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease
by: van Geffen WH, et al.
Published: (2018-04-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

Do 'guidelines' really guide us?
by: Milićević-Nešić Ivana J.
Published: (2017-01-01)